Savella and Methotrexate sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Savella (milnacipran hydrochloride) and Methotrexate sodium (methotrexate sodium). Common drug interactions include drug hypersensitivity among females.

The phase IV clinical study analyzes what interactions people have when they take Savella and Methotrexate sodium. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Savella?

Savella has active ingredients of milnacipran hydrochloride. It is often used in fibromyalgia. eHealthMe is studying from 7,529 Savella users. Check the latest studies of Savella.

What is Methotrexate sodium?

Methotrexate sodium has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 97,679 Methotrexate sodium users. Check the latest studies of Methotrexate sodium.



On Jul, 07, 2026

23 people who take Savella and Methotrexate sodium together, and have interactions are studied.

Savella and Methotrexate sodium drug interactions.

What are the common drug interactions of Savella and Methotrexate Sodium, by gender? *:

female:

  1. Drug hypersensitivity
  2. Drug ineffective
  3. Lung disorder (lung disease)
  4. Mood altered (changes in mood)
  5. Muscle tightness
  6. Myalgia (muscle pain)
  7. Peripheral swelling
  8. Rash
  9. Reading disorder (problem in areas of the brain that help interpret language)
  10. Weight increased

male:

n/a

What are the common drug interactions of Savella and Methotrexate Sodium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Arthralgia (joint pain)
  2. Chills (felling of cold)
  3. Migraine (headache)
  4. Oedema peripheral (superficial swelling)
  5. Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
  6. Throat irritation

50-59:

  1. Drug hypersensitivity
  2. Anaphylactic reaction (serious allergic reaction)
  3. Blood glucose increased
  4. Chest pain
  5. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  6. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  7. Hypoxia (low oxygen in tissues)
  8. Infusion related reaction

60+:

  1. Drug hypersensitivity
  2. Reading disorder (problem in areas of the brain that help interpret language)
  3. Dyspnoea (difficult or laboured respiration)
  4. Fatigue (feeling of tiredness)
  5. Glaucoma (increased fluid pressure in the eye with vision loss)
  6. Joint swelling
  7. Leukopenia (less number of white blood cells in blood)
  8. White blood cell count decreased
  9. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  10. Arthralgia (joint pain)

What are the existing conditions these people have? *

  1. Pain: 5 people, 21.74%
  2. Peripheral Swelling: 3 people, 13.04%
  3. Depression: 3 people, 13.04%
  4. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 8.70%
  5. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 8.70%
  6. Cardiac Disorder: 2 people, 8.70%
  7. Affective Disorder (mental disorder): 2 people, 8.70%
  8. Abdominal Pain Upper: 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Savella and Methotrexate sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Savella and Methotrexate sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Savella:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Methotrexate sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Savella and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methotrexate sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on milnacipran hydrochloride and methotrexate sodium (the active ingredients of Savella and Methotrexate sodium, respectively), and Savella and Methotrexate sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: